Florent Puisset

10PUBLICATIONS
10CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)BiomaterialsPharmacogenomicsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Toxicology (incl. clinical toxicology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 26, 2026
Galenic Modification as an Alternative Strategy for Administering Oral Anticancer Drugs: Assessment of Bioequivalence.

|Mar 01, 2023
Investigating the clinical impact of dose-banding for weekly paclitaxel in patients with breast cancer: A retrospective and monocentric study.

Florent Puisset, Félicien Le Louedec, Florence Dalenc

|Dec 09, 2022
Retrospective, real-life study of venetoclax plus azacitidine or low-dose cytarabine in French patients with acute myeloid leukemia ineligible for intensive chemotherapy.

Louise Laloi, Natacha Chaumard Billotey, Pierre-Yves Dumas

|Aug 03, 2021
Easy and reliable maximum a posteriori Bayesian estimation of pharmacokinetic parameters with the open-source R package mapbayr.

Félicien Le Louedec, Florent Puisset, Fabienne Thomas

|Oct 26, 2020
Brentuximab vedotin in real life, a seven year experience in patients with refractory/relapsed CD30+ T cell lymphoma.

Lucie Oberic, Faustine Delzor, Caroline Protin

|Jan 15, 2020
Association between clinically relevant toxicities of pazopanib and sunitinib and the use of weak CYP3A4 and P-gp inhibitors.

Camille Azam, Pauline Claraz, Christine Chevreau

Pageof 2

Frequent Collaborators

2 joint publications

Étienne Chatelut

1 joint publications

Félicien Le Louedec

1 joint publications

Fabienne Thomas

1 joint publications

Mélanie White-Koning